Allianz Asset Management GmbH - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q1 2023$1,200,864
-28.6%
11,200
-38.1%
0.00%0.0%
Q2 2022$1,683,000
-20.8%
18,1050.0%0.00%0.0%
Q1 2022$2,125,000
-70.3%
18,105
-65.8%
0.00%
-60.0%
Q4 2021$7,148,000
+2.7%
53,015
+21.4%
0.01%0.0%
Q3 2021$6,959,000
+213.0%
43,660
+158.4%
0.01%
+150.0%
Q2 2021$2,223,000
-46.5%
16,895
-47.6%
0.00%
-50.0%
Q1 2021$4,153,000
-27.8%
32,225
-6.5%
0.00%
-33.3%
Q4 2020$5,749,000
+8.1%
34,4700.0%0.01%0.0%
Q3 2020$5,319,000
-7.2%
34,470
-11.0%
0.01%
-14.3%
Q2 2020$5,729,000
+37.2%
38,740
+4.4%
0.01%
+16.7%
Q1 2020$4,177,000
-22.0%
37,095
-3.6%
0.01%
+20.0%
Q4 2019$5,354,000
+34.6%
38,480
-6.8%
0.01%
+25.0%
Q3 2019$3,977,000
-36.5%
41,305
-24.0%
0.00%
-33.3%
Q2 2019$6,260,000
-7.4%
54,360
-5.3%
0.01%
-14.3%
Q1 2019$6,759,000
+151.0%
57,430
+31.1%
0.01%
+133.3%
Q4 2018$2,693,000
-51.3%
43,820
-43.9%
0.00%
-40.0%
Q3 2018$5,535,000
-43.6%
78,120
-47.0%
0.01%
-50.0%
Q2 2018$9,809,000
-16.1%
147,460
-17.5%
0.01%
-9.1%
Q1 2018$11,689,000
+63.6%
178,720
+0.2%
0.01%
+83.3%
Q4 2017$7,145,000
+63.7%
178,370
+48.1%
0.01%
+50.0%
Q3 2017$4,366,000120,4500.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 5,909,742$911,991,00016.68%
Vivo Capital, LLC 1,797,745$277,428,00016.03%
Sofinnova Investments, Inc. 1,109,874$171,276,00012.70%
Asymmetry Capital Management, L.P. 81,442$12,568,0008.08%
Ghost Tree Capital, LLC 130,000$20,062,0005.80%
Eversept Partners, LP 161,004$24,846,1375.52%
Eventide Asset Management 1,709,848$263,864,0005.16%
Avoro Capital Advisors LLC 1,800,000$277,776,0003.95%
BERYLSON CAPITAL PARTNERS, LLC 72,700$11,219,0003.93%
Spyglass Capital Management LLC 547,022$84,416,0003.90%
View complete list of ASCENDIS PHARMA A/S shareholders